Latest filing published 30 Apr 2014 for Valeant Pharmaceuticals International, Inc..
No signal scores available.
All filings by Ryan Weldon on record concern Valeant Pharmaceuticals International, Inc. The record holds 15 filings, for trades running from 31 May 2013 to 28 April 2014.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 30 April 2014, reports an option exercise in Valeant Pharmaceuticals International, Inc. Between a trade and the moment it shows up on SEDI, the median delay is 4 days. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations